Oncology and Therapy

期刊简介：Now indexed in PubMedAims and ScopeOncology and Therapy is an international, peer reviewed, rapid-publication (peer review in 2 weeks, published 3–4 weeks from acceptance) journal dedicated to the publication of high-quality pre-clinical, clinical (all phases), observational, real-world, and health outcomes research around the discovery, development, and use of therapeutics and interventions (including devices) across all therapeutic areas. Studies relating to diagnostics and diagnosis, pharmacoeconomics, public health, epidemiology, quality of life, and patient care, management, and education are also encouraged.The journal is of interest to a broad audience of healthcare professionals and publishes original research, reviews, communications and letters. The journal is read by a global audience and receives submissions from all over the world. Oncology and Therapy will consider all scientifically sound research be it positive, confirmatory or negative data. Submissions are welcomed whether they relate to an international and/or a country-specific audience, something that is crucially important when researchers are trying to target more specific patient populations. This inclusive approach allows the journal to assist in the dissemination of all scientifically and ethically sound research.Rapid PublicationThe journal’s rapid publication timelines aim for a peer review decision within 2 weeks of submission. If an article is accepted it will be published online 3-4 weeks from acceptance. These rapid timelines are achieved through the combination of a dedicated in-house editorial team, who closely manage article workflow, and an extensive Editorial and Advisory Board who assist with rapid peer review. This allows the journal to support the rapid dissemination of research, whilst still providing robust peer review. Combined with the journal’s open access model this allows for the rapid and efficient communication of the latest research and reviews, allowing the advancement of clinical therapies.Personal ServiceThe journal’s dedicated in-house editorial team offer a personal “concierge service” meaning that authors will always have a personal point of contact able to update them on the status of their manuscript. The editorial team check all manuscripts to ensure that articles conform to the most recent COPE, GPP and ICMJE publishing guidelines. This supports the publication of ethically sound and transparent research. We also encourage pre-submission enquiries and are always happy to provide a confidential assessment of manuscripts. Digital features and plain language summariesOncology and Therapy offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by key summary points, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. If you consider that your paper would benefit from the inclusion of a digital feature, please let us know. Our editorial team are able to create high-quality slide decks and infographics in-house, and video abstracts through our partner Research Square, and would be happy to assist in any way we can. For further information about digital features, please contact the journal editor (see ‘Contact the Journal’ for email address), and see the ‘Guidelines for digital features and plain language summaries’ document under ‘Submission guidelines’.PreprintsWe encourage posting of preprints of primary research manuscripts on preprint servers, authors' or institutional websites, and open communications between researchers whether on community preprint servers or preprint commenting platforms. Posting of preprints is not considered prior publication and will not jeopardize consideration in our journals.Please see here for further information on preprint sharing: https://www.springer.com/gp/authors-editors/journal-author/journal-author-helpdesk/submission/1302#c16721550Peer Review ProcessUpon submission, manuscripts are assessed by the editorial team to ensure they fit within the aims and scope of the journal and are also checked for plagiarism. All suitable submissions are then subject to a comprehensive single-blind peer review. Reviewers are selected based on their relevant expertise and publication history in the subject area. The journal has an extensive pool of editorial and advisory board members who have been selected to assist with peer review based on the afore-mentioned criteria.At least two extensive reviews are required to make the editorial decision, with the exception of some article types such as Commentaries, Editorials and Letters which are generally reviewed by one member of the Editorial Board. Where reviewer recommendations are conflicted, the editorial board will be contacted for further advice and a presiding decision.Manuscripts are then either accepted, rejected or authors are required to make major or minor revisions (both reviewer comments and editorial comments may need to be addressed). Once a revised manuscript is re-submitted, it is assessed along with the responses to reviewer comments and if it has been adequately revised it will be accepted for publication. Accepted manuscripts are then copyedited and typeset by the production team before online publication. Appeals against decisions following peer review are considered on a case by case basis and should be sent to the journal editor.CopyrightOncology and Therapy's content is published open access under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, click here: http://creativecommons.org/licenses/by-nc/4.0Publication FeesUpon acceptance of an article, authors will be required to pay the mandatory Rapid Service Fee of £3650/€4500/$5100. The journal will consider fee discounts for developing countries and this is decided on a case by case basis.Open AccessAll articles published by Oncology and Therapy are published open accessContactFor more information about the journal, including pre-submission enquiries, please contact managing editor Lydia Alborn at lydia.alborn@springer.com.

【译文】《肿瘤学与治疗》是一本国际性的同行评审期刊，致力于发表高质量的预临床、临床（所有阶段）、观察性、真实世界和健康结果研究，内容涵盖所有治疗领域的药物和干预措施（包括设备）的发现、开发和使用。鼓励发表与诊断和诊断、药物经济学、公共卫生、流行病学、生活质量以及患者护理、管理和教育相关的研究。该期刊对广泛的医疗保健专业人士感兴趣，并发表原创研究、综述、通讯和信件。该期刊被全球读者阅读，并接受来自世界各地的投稿。肿瘤学与治疗将考虑所有科学上可靠的研究，无论是阳性、证实性还是阴性数据。无论稿件是否针对国际和/或特定国家的受众，这都是研究人员试图针对更具体的患者群体时至关重要的。这种包容性方法使期刊能够帮助传播所有科学和伦理上可靠的研究。快速出版该期刊的快速出版时间表旨在在提交后2周内做出同行评审的决定。如果文章被接受，它将在接受后3-4周内在线出版。这些快速时间表是通过结合专门的内部编辑团队和广泛的编辑和顾问委员会来实现的，他们协助快速同行评审。这使期刊能够支持研究的快速传播，同时仍然提供稳健的同行评审。结合期刊的开放获取模式，这允许快速有效地传播最新的研究和综述，从而推动临床治疗的发展。个性化服务该期刊的专门内部编辑团队提供个性化的“礼宾服务”，这意味着作者将始终有一个个人联系人，能够更新他们关于其手稿状态的信息。编辑团队检查所有手稿，以确保文章符合最新的COPE、GPP和ICMJE出版指南。这支持了道德上透明的研究的出版。我们还鼓励预先提交询问，并且总是愿意提供手稿的保密评估。数字功能和通俗易懂的摘要肿瘤学与治疗提供了一系列旨在增加期刊内容可见性、读者群和教育价值的附加功能。每篇文章都附有关键摘要点，为广泛的读者提供内容的高效概述。文章可能附有通俗易懂的摘要，以帮助那些对该领域有一定了解但不是深入了解的读者理解科学内容和文章的整体影响。该期刊还提供包括动画摘要、视频摘要、幻灯片、音频幻灯片、教学视频、信息图表、播客和动画在内的各种数字功能。所有附加功能都经过与文章本身相同的高标准同行评审。如果您认为您的论文受益于包含数字功能，请告知我们。我们的编辑团队能够内部创建高质量的幻灯片和信息图表，并通过我们的合作伙伴Research Square创建视频摘要，并愿意以任何方式提供帮助。有关数字功能的更多信息，请联系期刊编辑（请参阅“联系期刊”以获取电子邮件地址），并在“投稿指南”下查看“数字功能和通俗易懂的摘要指南”文件。预印本我们鼓励在预印本服务器、作者或机构网站上发布主要研究手稿的预印本，以及研究人员在社区预印本服务器或预印本评论平台上的开放交流。预印本的发布不被视为先前发表，并且不会损害我们期刊的考虑。有关预印本共享的更多信息，请参阅此处：https://www.springer.com/gp/authors-editors/journal-author/journal-author-helpdesk/submission/1302#c16721550同行评审流程提交后，手稿将由编辑团队评估，以确保它们符合期刊的目标和范围，并检查是否存在剽窃。所有合适的投稿都将接受全面的单盲同行评审。评审员根据其在相关领域的专业知识发表历史进行选择。该期刊有一批广泛的编辑和顾问委员会成员，他们根据上述标准被选中协助同行评审。至少需要两篇广泛的评论来做出编辑决定，除非是某些类型的文章，如评论、社论和信件，通常由编辑委员会的一名成员进行评审。如果评审员建议存在冲突，编辑委员会将获得进一步建议和最终决定。然后，手稿将被接受、拒绝或要求作者进行重大或轻微的修改（可能需要解决评审员和编辑的评论）。一旦修订的手稿重新提交，它将与对评审员评论的回应一起评估，如果已充分修订，它将被接受发表。接受的手稿随后将由制作团队进行校对和排版，然后在线出版。对同行评审后的决定提出的上诉将根据个案进行考虑，并应发送给期刊编辑。版权《肿瘤学与治疗》的内容在Creative Commons Attribution-Noncommercial许可证下以开放获取方式出版，允许用户阅读、复制、分发和为非商业目的从材料中制作衍生作品，只要原始作品的作者得到引用。作者将文章的任何商业用途的独家权利赋予Springer。有关Creative Commons Attribution-Noncommercial许可证的更多信息，请点击此处：http://creativecommons.org/licenses/by-nc/4.0出版费用文章被接受后，作者将被要求支付强制性快速服务费3650英镑/4500欧元/5100美元。该期刊将考虑发展中国家的费用折扣，并将在个案基础上决定。开放获取《肿瘤学与治疗》发表的所有文章都是开放获取的。